ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Working Group Proposes “Equitable” Schema For Determining Cancer Center Core Grants

July 3, 2013

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014

Advisors say NCI needs to reach out to other fields.

July 15, 2005

Enzastaurin Shows Activity In Recurrent High-Grade Glioma

June 24, 2005

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008